miRNA-21 regulates arsenic-induced anti-leukemia activity in myelogenous cell lines. [electronic resource]
Producer: 20110802Description: 211-8 p. digitalISSN:- 1559-131X
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Apoptosis Regulatory Proteins -- antagonists & inhibitors
- Arsenic Trioxide
- Arsenicals -- pharmacology
- Blotting, Western
- Cell Cycle -- drug effects
- Cell Proliferation -- drug effects
- Flow Cytometry
- Humans
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Leukemia, Myeloid, Acute -- drug therapy
- MicroRNAs -- physiology
- Oxides -- pharmacology
- RNA, Messenger -- genetics
- RNA-Binding Proteins -- antagonists & inhibitors
- Reverse Transcriptase Polymerase Chain Reaction
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.